HU-211 – 5 mg

Brand:
Cayman
CAS:
112924-45-5
Storage:
-20
UN-No:
Non-Hazardous - /

The endocannabinoids present a rich system of central cannabinoid (CB1), peripheral cannabinoid (CB2), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.{7912,7991} HU-211 is a synthetic terpene-based cannabinoid devoid of central cannabinoid (CB1) and peripheral cannabinoid (CB2) agonist activity, thus lacking the psychomotor responses characteristic of Δ9-THC. HU-211 does exhibit the neuroprotective, antioxidant properties of other related compounds like cannabidiol.{12977} HU-211 also has anti-inflammatory properties derived through inhibition of NF-κB and the resulting decreases in cytokines such as TNFα and interleukin-6.  

 

Available on backorder

SKU: 10006350 - 5 mg Category:

Description

A synthetic terpene-based CB devoid of CB1 and CB2 receptor agonist activity; exhibits neuroprotective, antioxidant, and anti-inflammatory properties


Formal name: 3-(1,1-dimethylheptyl)-6aS,7,10,10aS-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol

Synonyms:  Dexanabinol

Molecular weight: 386.6

CAS: 112924-45-5

Purity: ≥98%

Formulation: A crystalline solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Drugs of Abuse||Research Area|Forensic Chemistry & Toxicology|Cannabinoids|Synthetic Cannabinoids||Research Area|Forensic Chemistry & Toxicology|Terpenoids & Terpenes